Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Luiten, Rosalie M.a | Warnaar, Sven O.a | Schuurman, Janineb | Pasmans, Suzanne G.M.A.b | Latour, Sylvainc | Daëron, Marcc | Fleuren, Gert Jana | Litvinov, Sergey V.a; *
Affiliations: [a] Department of Pathology, University of Leiden, Leiden, The Netherlands | [b] Department of Allergy, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB), Amsterdam, The Netherlands | [c] Laboratoire d'Immunologie Cellulaire & Clinique, INSERM U. 255, Institut Curie, Paris, France
Correspondence: [*] Correspondence and reprint requests to: Dr. S.V. Litvinov, Department of Pathology, University of Leiden, University Hospital Building 1, L1-Q, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
Abstract: Crosslinking of immunoglobulin E molecules that are bound to the Fcε receptors expressed on mast cells or basophils triggers activation of these cells, resulting in the development of a type I hypersensitivity. Targeting this potent immune reaction towards tumors by using IgE that reacts with a tumor-associated antigen, may induce a local inflammation at the tumor site, and may therefore promote tumor regression. We have previously shown that murine IgE bound to tumor cells can activate murine mast cells to release TNF-α and histamine. To further investigate the therapeutic potential of IgE-mediated immunotherapy of carcinomas, we have developed human/murine chimeric versions, containing the murine variable regions and human constant regions, of both G250 and 323/A3 IgE. These chimeric IgEs are reactive respectively with the G250 renal cell carcinoma antigen and the Ep-CAM molecule, which is highly expressed by most carcinomas. Transfection of the respective chimeric heavy and light chain genes into recipient Sp2/0 myeloma cells yielded chimeric IgE-producing clones. Chimeric G250 and 323/A3 IgE reacted with tumor cells expressing the G250 antigen or Ep-CAM, respectively. To generate a cell line that expresses Fe receptors for human or chimeric IgE, the rat basophilic leukemia cell line RBL-7 was transfected with the human FcεRI α chain (RBL-7TZ) and subsequently tested for binding of chimeric IgE. Functional assays showed that both chimeric IgEs activated RBL-7TZ cells to release TNF-α when cultured with tumor cells that express the respective specific antigen. Furthermore, both chimeric IgEs were able to activate freshly isolated human basophils.
Keywords: Chimeric immunoglobulin E, renal cell carcinoma, mast cells
DOI: 10.3233/HAB-1997-8402
Journal: Human Antibodies, vol. 8, no. 4, pp. 169-180, 1997
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl